Nimble and Bulking-Up, CaniBrands Raising $5.0 Million for Expansion
November 11th, 2019
App, Exclusive, News, Top Story
Agile like the superstar athletes supporting their science, CaniBrands made the decision earlier this year to divest its THC business to focus exclusively on its CBD operations ahead of its go-public transaction anticipated for 2020. With a day-to-night portfolio of products and multi-channel distribution, the company has set out to raise $5.0 million to continue rapidly scaling its business.
In the emerging cannabis market forecast by Grand View Research to hit $66.3 billion by 2025, many companies are a mile wide and an inch deep as they look to capitalize on every trend. Not CaniBrands. The savvy management team has extensive experience in consumer packaged goods and branding and after only a few months in the THC market, it was quickly realized that the byzantine nature, flood of competitors and low margins didn’t make sense for them. However, the opportunity to be differentiated in the CBD market did.
The Prescient Move to CBD, Superstar Support
To many, cannabis is often confused with some of its compounds and remains a gray area because of a misunderstanding of the difference between THC (tetrahydrocannabinol) and CBD (cannabidiol). In short, THC is responsible for the “high” associated with cannabis, while CBD has zero psychoactive qualities. CBD is widely trumpeted for a litany of health benefits and can also be derived from hemp, which, by definition contains little or no THC. The passage of the 2018 U.S. Farm Bill legalized hemp nationwide, opening up interstate and international commerce for hemp-derived CBD. Cannabis, THC and CBD from marijuana are 100% illegal at the federal level.
This topic is touched on in a recorded conversation between 12-time Olympic medalist Dara Torres and acclaimed high-performance trainer Andy O’Brien. Torres serves as a global spokesperson for CaniBrands, while O’Brien is the company’s Sport Science Advisor. Apropos, Paul Bissonnette, a retired NHL player and founder of the wildly popular Spittin’ Chiclets Barstool Sports Podcast, is CaniBrands’ Sport Media Ambassador.
Dara Torres 12-time Olympic medalist
Former NHL play Paul Bissonnette
Hundreds of professional athletes have come forward in recent years in support of the medicinal benefits of CBD to combat inflammation, pain and other conditions, particularly as an alternative to addictive prescription drugs like opioids. Adding Torres, O’Brien and Bissonnette as brand ambassadors speaks volumes to the quality of CaniBrands products and gives the company a loudspeaker to millions of followers and fans for their marketing efforts.
Focusing on hemp-based CBD is savvy for many reasons. The company runs extremely lean, avoids capex related to regulations with THC products, has massive distribution potential and, maybe most importantly, is taking a lead in a market driver. According to a first-of-its-kind study by Manifest7 recently, there is a school of thought that medicinal applications are the future of cannabis, not recreational uses.
Arc View sees the U.S. CBD market climbing from $800 million in 2018 to $20 billion by 2024.
Take What They’re Giving You
Every good athlete knows the key to victory is often in taking what is easily available. A hockey goalie struggles when facing a lot of shots on goal? Don’t look for the perfect shot; keep firing away. A football defense can’t stop the run? Don’t spend the game throwing; hand it to your running back.
Taking the concept to business, right now U.S. regulators are supportive of hemp-derived CBD. Sure, there are some indications that cannabis prohibition is futile, but building a brand in a higher margin model that allows ubiquitous sales is easily the path of least resistance. Get name recognition now, expand within your lane and see where the future takes the company.
Utilizing ingenuity that sets it apart from competition, this is exactly the playbook CaniBrands is following.
CaniBrands already offers the premium product lines dubbed Can-i boost, Can-i mend, Can-i fresh and Can-i sleep through its growing distribution channels across the U.S., including Amazon.com and other e-commerce locations with brick-and-mortar sales part of the go-forward strategy. Considering these products command margins of 60%+, it is not hard to see why management left THC products behind and is leaning on the direct-to-consumer portion of its business.
Some companies are making a mistake by thinking they can win over consumers by taking existing products and simply packing CBD in them. With a flood of products coming to market, consumers are reacting and associating with novel products with science-backed wellness benefits. CaniBrands’ products are innovative with the formulations differentiated through the addition of nutraceuticals for high efficacy. Consumers can feel confident in the products given that all are third-party tested in a GMP-compliant and FDA-certified facility.
So far, the consumer response has been positive at worst, extraordinary at best. A stunning 92% of customers say they would recommend CaniBrands products. The company’s net promoter score, a management tool used in the industry as a barometer of loyalty typically correlated with revenue growth, recently came in at 55. That’s a score higher than the national average and the likes of Apple, Amazon, Pepsi, Kraft and many other household names.
Comments are one thing, but consumers opening their wallets is another. The data reinforces brand loyalty being strong. The average order for Canibrands products is $102, which is higher than competitors offering similar products. Importantly, the value of the average shopping cart is up 26% even though usage of incentive codes has dropped 40%. Moreover, buyers are coming back quickly, as measured by an average return time between purchases of just over a month (34 days).
With the momentum gathering, the company is readying to launch products into key international markets. Canada is first on tap, with sales expected to commence in January 2020.
Additional scaling strategies include launching Softgels, beverage and other product forms (topicals, CBD bars, ready-mix powders, etc.); developing products with other cannabinoids (e.g. CBN, CBG); licensing and co-manufacturing in more international markets; relaunching OMG Farms CBD brand; and expanding the CaniBuy™ e-commerce management platform. CaniBuy is robust online architecture integrating websites, e-commerce, payments and fulfillment in one, client-facing portal.
$5.0 Million Raise
With no long-term debt, a seasoned team, increasing sales and a solid business model, CaniBrands is ready for the next phase of expansion. To that end, the company has initiated a $5.0 million capital raise. CaniBrands’ founders and two strategic investors have already committed to more than $1.0 million of the funding round. Management says the proceeds will be used for a variety of revenue-driving activities, as well as R&D and general operational expenses.
CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on https://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.